Experimental No treatment,Active Comparator Drug

4 trials

Sponsors

Faculty of Medicine, Chulalongkorn University, Department of Medicine, Phramongkutklao Hospital

Conditions

A randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactions A randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactionsChronic hepatitis B Hepatitis BHIV infection with CD4 count below 200 cells per microliter and risk of Pneumocystis jirovecii pneumonia HIV InfectionsHypersensitivity reactions in patients who received taxane chemotherapy regimen between standard premedication protocol and modified premedication protocol without ranitidine. Hypersensitivity reactions in patients who received taxane chemotherapy regimen between standard premedication protocol and modified premedication protocol without ranitidine.

Phase 3

Efficacy of Premedication Protocol Without Ranitidine for Taxane Regimen : A Multicenter Non-Randomized Historical Controlled Study

Active, not recruitingTCTR20210322004

Hypersensitivity reactions in patients who received taxane chemotherapy regimen between standard premedication protocol and modified premedication protocol without ranitidine. Hypersensitivity reactions in patients who received taxane chemotherapy regimen between standard premedication protocol and modified premedication protocol without ranitidine.

Start: 2021-03-23Target: 200Updated: 2026-08-03

A randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactions

Active, not recruitingTCTR20220913005

A randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactions A randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactions

Start: 2022-09-19Target: 140Updated: 2026-08-03

Phase 4

Re-treatment Strategies after Stopping Nucleos(t)ide Analogues in HBeAg-negative and Non-cirrhotic Chronic Hepatitis B Patients: A Single-blinded Randomized-controlled Trial

Active, not recruitingTCTR20240818004

Faculty of Medicine, Chulalongkorn UniversityChronic hepatitis B Hepatitis B

Start: 2024-11-01Target: 74Updated: 2026-08-03

Evaluating the Necessity and Safety of Co-trimoxazole Prophylaxis in People Living with HIV Initiating Rapid ART with Low CD4 Counts: A Multicenter Randomized Controlled Trial

RecruitingTCTR20260116002

Department of Medicine, Phramongkutklao HospitalHIV infection with CD4 count below 200 cells per microliter and risk of Pneumocystis jirovecii pneumonia HIV Infections

Start: 2025-12-22Target: 64Updated: 2026-08-03